Trial intelligence / Profile preview

Propranolol Combined with Doxorubicin in Metastatic Soft Tissue Sarcoma

NCT03108300Phase 2Unknown

Sponsor
Ain Shams University
Start
Aug 2019
Primary completion
Aug 2020
Modality
Small Molecules
01

Overview

A Phase 2 trial of propranolol in soft tissue sarcoma (STS), sponsored by Ain Shams University. Status: unknown.

02

Drugs

propranolol
03

Conditions

soft tissue sarcoma (STS)

Beyond the preview

Go deeper on NCT03108300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03108300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call